Clinical Trial Supply & Logistics Market To Reach $6.72 Billion By 2030

Clinical Trial Supply & Logistics Market Growth & Trends

The global clinical trials supply & logistics market size is estimated to reach USD 6.72 billion by 2030, expanding at a CAGR of 7.97% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rise in advanced technology and innovations in the clinical trial supply & logistics market, implementation of stringent regulations, and the rising demand for clinical trials due to the increasing prevalence of diseases such as the COVID-19 pandemic.

Initially, the COVID-19 pandemic negatively impacted the market due to disruption in the supply chain and a reduction in commercial airlines by the government to prevent the spread of the virus. However, the market soon recovered and started to grow significantly due to rising demand for the COVID-19 vaccine to prevent this disease. For instance, according to WHO, as of August 2, 2022, there are 169 vaccines in the clinical development stage and 198 vaccines in the preclinical phase.

There has been significant investment in supply chain management software by clinical trial supplies providers. Growing complexity in clinical trials and increased competition among market players are factors responsible for the adoption of new technologies in supply chain management. The need for software for inventory management, supply chain planning, and ancillary supply chain management is expected to grow, owing to the increasing adoption of new technologies by industry players.

 Request a free sample copy or view report summary: Clinical Trials Supply & Logistics Market Report

Clinical Trial Supply & Logistics Market Report Highlights

• In service segment, logistics & distribution dominated the market in 2024 with a share of 25.3%. This is due to the rise in clinical trials due to COVID- 19 pandemic

• Based on phase, The phase III segment accounted for the largest revenue share in 2024

• Based on therapeutic area, the cardiovascular diseases segment held the largest market share in 2024. This is due to the rise in the number of investments by market players for bringing novel and innovation to the market

• North America dominated the market with a revenue share of 38.33% in 2024.The region accounts for the highest number of clinical trials conducted among all regions, which is a major driver for growth of clinical trial supply and logistics market.

Clinical Trial Supply & Logistics Market Segmentation

Grand View Research has segmented the global clinical trials supply & logistics market based on service, phase, therapeutic area, end use, and region:

Clinical Trial Supply & Logistics Service Outlook (Revenue, USD Million, 2018 - 2030)

• Logistics & Distribution

• Storage & Retention

• Packaging, Labeling, and Blinding

• Manufacturing

• Comparator Sourcing

• Other Services

Clinical Trial Supply & Logistics Phase Outlook (Revenue, USD Million, 2018 - 2030)

• Phase I

• Phase II

• Phase III

• Phase IV

Clinical Trial Supply & Logistics Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)

• Oncology

• Cardiovascular Diseases

• Respiratory Diseases

• CNS and Mental Disorders

• Others

Clinical Trial Supply & Logistics End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceuticals

• Biologicals

• Medical Device

Clinical Trial Supply & Logistics Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

  • Colombia

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Clinical Trial Supply & Logistics Market

• Thermo Fisher Scientific Inc.

• UPS Healthcare

• Piramal Pharma Solutions

• DHL

• Parexel International

• Almac Group

• Movianto

• UDG Healthcare

• FedEx

• Catalent, Inc.